Bacterial Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Bacterial Conjunctivitis symptoms include redness in the white of the eye or inner eyelid, itchy eyes, blurred vision, increased sensitivity to light and burning eyes. Treatment includes antibiotics.
The Bacterial Conjunctivitis pipeline drugs market research report provides an analysis of the Bacterial Conjunctivitis drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Bacterial Conjunctivitis and features dormant and discontinued projects.
Key Targets of the Bacterial Conjunctivitis Pipeline Drugs Market
Some of the targets of the Bacterial Conjunctivitis pipeline drugs market are DNA Gyrase, DNA Topoisomerase IV, DNA, DNA Primase, Glucocorticoid Receptor, Prostaglandin G/H Synthase 1, Prostaglandin G/H Synthase 2, and Staphylococcus aureus Alpha Hemolysin.
Bacterial Conjunctivitis Pipeline Drugs Market, by Key Targets
For more insights on key targets, download a free report sample
Key Mechanisms of Action in the Bacterial Conjunctivitis Pipeline Drugs Market
The key mechanisms of action of the Bacterial Conjunctivitis pipeline drugs market are DNA Gyrase Inhibitor, DNA Topoisomerase IV Inhibitor, DNA Primase Inhibitor, DNA Synthesis Inhibitor, Glucocorticoid Receptor Agonist, Prostaglandin G/H Synthase 1 Inhibitor, and Prostaglandin G/H Synthase 2 Inhibitor.
Bacterial Conjunctivitis Pipeline Drugs Market, by Key Mechanisms of Action
For more insights on key mechanisms of action, download a free report sample
Key Routes of Administration in the Bacterial Conjunctivitis Pipeline Drugs Market
The routes of administration in the Bacterial Conjunctivitis pipeline drugs market are ophthalmic, topical, inhalational, oral, parenteral, and vaginal.
Bacterial Conjunctivitis Pipeline Drugs Market, by Routes of Administration
For more insights on routes of administration, download a free report sample
Key Molecule Types in the Bacterial Conjunctivitis Pipeline Drugs Market
The molecule types in the Bacterial Conjunctivitis pipeline drugs market are Small Molecule and Biologic.
Bacterial Conjunctivitis Pipeline Drugs Market, by Molecule Types
For more insights on molecule type, download a free report sample
Key Companies in the Bacterial Conjunctivitis Pipeline Drugs Market
Some of the key companies in the Bacterial Conjunctivitis pipeline drugs market are Cellics Therapeutics Inc, IACTA Pharmaceuticals Inc, NTC srl, TaeJoon Pharmaceuticals Co Ltd, Takeda Pharmaceutical Co Ltd, and TGV-Inhalonix Inc among others.
Bacterial Conjunctivitis Pipeline Drugs Market, by Companies
For more insights on companies, download a free report sample
Bacterial Conjunctivitis Pipeline Drugs Market Report Overview
Key Targets | DNA Gyrase, DNA Topoisomerase IV, DNA, DNA Primase, Glucocorticoid Receptor, Prostaglandin G/H Synthase 1, Prostaglandin G/H Synthase 2, and Staphylococcus aureus Alpha Hemolysin |
Key Mechanisms of Action | DNA Gyrase Inhibitor, DNA Topoisomerase IV Inhibitor, DNA Primase Inhibitor, DNA Synthesis Inhibitor, Glucocorticoid Receptor Agonist, Prostaglandin G/H Synthase 1 Inhibitor, and Prostaglandin G/H Synthase 2 Inhibitor |
Key Routes of Administration | Ophthalmic, Topical, Inhalational, Oral, Parenteral and Vaginal |
Key Molecule Types | Small Molecule and Biologic |
Key Companies | Cellics Therapeutics Inc, IACTA Pharmaceuticals Inc, NTC srl, TaeJoon Pharmaceuticals Co Ltd, Takeda Pharmaceutical Co Ltd, and TGV-Inhalonix Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Bacterial Conjunctivitis (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Bacterial Conjunctivitis (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Bacterial Conjunctivitis (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Bacterial Conjunctivitis (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Bacterial Conjunctivitis (Ophthalmology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Bacterial Conjunctivitis (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Bacterial Conjunctivitis (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
IACTA Pharmaceuticals Inc
NTC srl
TaeJoon Pharmaceuticals Co Ltd
Takeda Pharmaceutical Co Ltd
TGV-Inhalonix Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets of the Bacterial Conjunctivitis pipeline drugs market?
Some of the targets of the Bacterial Conjunctivitis pipeline drugs market are DNA Gyrase, DNA Topoisomerase IV, DNA, DNA Primase, Glucocorticoid Receptor, Prostaglandin G/H Synthase 1, Prostaglandin G/H Synthase 2, and Staphylococcus aureus Alpha Hemolysin.
-
What are the mechanisms of action of the Bacterial Conjunctivitis pipeline drugs market?
The key mechanism of action of the Bacterial Conjunctivitis pipeline drugs market are DNA Gyrase Inhibitor, DNA Topoisomerase IV Inhibitor, DNA Primase Inhibitor, DNA Synthesis Inhibitor, Glucocorticoid Receptor Agonist, Prostaglandin G/H Synthase 1 Inhibitor, and Prostaglandin G/H Synthase 2 Inhibitor.
-
What are the routes of administration in the Bacterial Conjunctivitis pipeline drugs market?
The routes of administration in the Bacterial Conjunctivitis pipeline drugs market are ophthalmic, topical, inhalational, oral, parenteral and vaginal.
-
What are the molecule types in the Bacterial Conjunctivitis pipeline drugs market?
The molecule types in the Bacterial Conjunctivitis pipeline drugs market are Small Molecule and Biologic.
-
Which are the key companies in the Bacterial Conjunctivitis pipeline drugs market?
Some of the key companies in the Bacterial Conjunctivitis pipeline drugs market are Cellics Therapeutics Inc, IACTA Pharmaceuticals Inc, NTC srl, TaeJoon Pharmaceuticals Co Ltd, Takeda Pharmaceutical Co Ltd, and TGV-Inhalonix Inc among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.